Genetics and sports

British Medical Bulletin

Volumn 93, Issue 1, 2010, Pages 27-47

  Lippi, Giuseppe ^a   Longo, Umile Giuseppe ^b   Maffulli, Nicola ^c  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^c KEELE UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Athletic performance; Genetics; Sports

Indexed keywords

ADENOSINE MONOPHOSPHATE DEAMINASE; ALPHA ACTININ 3; ANTISENSE OLIGONUCLEOTIDE; BETA GALACTOSIDASE; BONE MORPHOGENETIC PROTEIN 12; BRAIN DERIVED NEUROTROPHIC FACTOR; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 5; CREATINE KINASE MM; DIPEPTIDYL CARBOXYPEPTIDASE; G PROTEIN COUPLED RECEPTOR KINASE 3; GA BINDING PROTEIN; GLYCOGEN SYNTHASE; GROWTH DIFFERENTIATION FACTOR 5; HEMOGLOBIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; MYOSIN LIGHT CHAIN KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; SEROTONIN TRANSPORTER; SOMATOMEDIN C; TENASCIN; TRANSFORMING GROWTH FACTOR BETA1; UNCOUPLING PROTEIN 2; VASCULOTROPIN;

APTITUDE; ATHLETIC PERFORMANCE; BLOOD GROUP ABO SYSTEM; DOPING; ENDURANCE; ENVIRONMENTAL FACTOR; EXERCISE; FITNESS; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETIC TRANSFECTION; GENOTYPE; GLUCOSE METABOLISM; HUMAN; INSULIN METABOLISM; LIGAMENT; MORPHOLOGY; MUSCLE FUNCTION; NONHUMAN; PHENOTYPE; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUANTITATIVE TRAIT LOCUS; REVIEW; SPORT; SPORT INJURY; TENDON; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ATHLETIC PERFORMANCE; GENETIC TESTING; GENOTYPE; HUMANS; MOTOR SKILLS; PHENOTYPE; PHYSICAL ENDURANCE;

EID: 77949393727     PISSN: 00071420     EISSN: 14718391     Source Type: Journal    
DOI: 10.1093/bmb/ldp007     Document Type: Review

References (100)

1. Van Damme R, Wilson RS, Vanhooydonck B, Aerts P (2002) Performance constraints in decathletes. Nature, 415, 755-756.
2. Bouchard C, Dionne FT, Simoneau JA, Boulay MR (1992) Genetics of aerobic and anaerobic performances. Exerc Sport Sci Rev, 20, 27-58.
3. Lippi G (2008) Genomics and sports: building a bridge towards a rational and personalized training framework. Int J Sports Med, 29, 264-265.
4. Rankinen T, Bray MS, Hagberg JM et al. (2006) The human gene map for performance and health-related fitness phenotypes: the 2005 update. Med Sci Sports Exerc, 38, 1863-1888.
5. Akhmetov II, Astranenkova IV, Rogozkin VA (2007) Association of PPARD gene polymorphism with human physical performance. Mol Biol (Mosk), 41, 852-857.
6. He Z, Hu Y, Feng L et al. (2007) NRF2 genotype improves endurance capacity in response to training. Int J Sports Med, 28, 717-721.
7. Calvo JA, Daniels TG, Wang X et al. (2008) Muscle-specific expression of PPAR{gamma} coactivator-1{alpha} improves exercise performance and increases peak oxygen uptake. J Appl Physiol, 104, 1304-1312.
8. Mason SD, Rundqvist H, Papandreou I et al. (2007) HIF-1alpha in endurance training: suppression of oxidative metabolism. Am J Physiol Regul Integr Comp Physiol, 293, R2059-R2069.
9. Henderson J, Withford-Cave JM, Duffy DL et al. (2005) The EPAS1 gene influences the aerobic-anaerobic contribution in elite endurance athletes. Hum Genet, 118, 416-423.
10. He Z, Hu Y, Feng L et al. (2006) Polymorphisms in the HBB gene relate to individual cardiorespiratory adaptation in response to endurance training. Br J Sports Med, 40, 998-1002.
11. An P, Teran-Garcia M, Rice T et al. (2005) Genome-wide linkage scans for prediabetes phenotypes in response to 20 weeks of endurance exercise training in non-diabetic whites and blacks: the HERITAGE Family Study. Diabetologia, 48, 1142-1149.
12. Wolfarth B, Rankinen T, Muhlbauer S et al. (2007) Association between a beta2-adrenergic receptor polymorphism and elite endurance performance. Metabolism, 56, 1649-1651.
13. Hautala AJ, Rankinen T, Kiviniemi AM et al. (2006) Heart rate recovery after maximal exercise is associated with acetylcholine receptor M2 (CHRM2) gene polymorphism. Am J Physiol Heart Circ Physiol, 291, H459-H466.
14. Prior SJ, Hagberg JM, Paton CM et al. (2006) DNA sequence variation in the promoter region of the VEGF gene impacts VEGF gene expression and maximal oxygen consumption. Am J Physiol Heart Circ Physiol, 290, H1848-H1855.
15. Beunen G, Thomis M (1999) Genetic determinants of sports participation and daily physical activity. Int J Obes Relat Metab Disord, 23 (Suppl 3), S55-S63.
16. Wolfarth B, Rivera MA, Oppert JM et al. (2000) A polymorphism in the alpha2a-adrenoceptor gene and endurance athlete status. Med Sci Sports Exerc, 32, 1709-1712.
17. Akhmetov II, Popov DV, Mozhaiskaia IA et al. (2007) Association of regulatory genes polymorphisms with aerobic and anaerobic performance of athletes. Ross Fiziol Zh Im I M Sechenova, 93, 837-843.
18. Saunders CJ, Xenophontos SL, CariolouMA, Anastassiades LC, Noakes TD, Collins M (2006) The bradykinin beta 2 receptor (BDKRB2) and endothelial nitric oxide synthase 3 (NOS3) genes and endurance performance during Ironman Triathlons. Hum Mol Genet, 15, 979-987.
19. Wang P, Ma LH, Wang HY et al. (2006) Association between polymorphisms of vitamin D receptor gene ApaI, BsmI and TaqI and muscular strength in young Chinese women. Int J Sports Med, 27, 182-186.
20. Bottinelli R, Reggiani C (2000) Human skeletal muscle fibres: molecular and functional diversity. Prog Biophys Mol Biol, 73, 195-262.
21. Bergh U, Thorstensson A, Sjodin B, Hulten B, Piehl K, Karlsson J (1978) Maximal oxygen uptake and muscle fiber types in trained and untrained humans. Med Sci Sports, 10, 151-154.
22. Rubio JC, Perez M, Mate-Munoz JL et al. (2008) AMPD1 genotypes and exercise capacity in McArdle patients. Int J Sports Med, 29, 331-335.
23. Echegaray M, Rivera MA (2001) Role of creatine kinase isoenzymes on muscular and cardiorespiratory endurance: genetic and molecular evidence. Sports Med, 31, 919-934.
24. Bouchard C, Chagnon M, Thibault MC et al. (1989) Muscle genetic variants and relationship with performance and trainability. Med Sci Sports Exerc, 21, 71-77.
25. Zhou DQ, Hu Y, Liu G, Gong L, Xi Y, Wen L (2006) Muscle-specific creatine kinase gene polymorphism and running economy responses to an 18-week 5000-m training programme. Br J Sports Med, 40, 988-991.
26. MacArthur DG, Seto JT, Raftery JM et al. (2007) Loss of ACTN3 gene function alters mouse muscle metabolism and shows evidence of positive selection in humans. Nat Genet, 39, 1261-1265.
27. Yang N, MacArthur DG, Gulbin JP et al. (2003) ACTN3 genotype is associated with human elite athletic performance. Am J Hum Genet, 73, 627-631.
28. MacArthur DG, Seto JT, Chan S et al. (2008) An Actn3 knockout mouse provides mechanistic insights into the association between alpha-actinin-3 deficiency and human athletic performance. Hum Mol Genet, 17, 1076-1086.
29. Lucia A, Gomez-Gallego F, Santiago C et al. (2006) ACTN3 genotype in professional endurance cyclists. Int J Sports Med, 27, 880-884.
30. Saunders CJ, September AV, Xenophontos SL et al. (2007) No association of the ACTN3 gene R577X polymorphism with endurance performance in Ironman Triathlons. Ann Hum Genet, 71, 777-781.
31. Clarkson PM, Hoffman EP, Zambraski E et al. (2005) ACTN3 and MLCK genotype associations with exertional muscle damage. J Appl Physiol, 99, 564-569.
32. Rieder MJ, Taylor SL, Clark AG, Nickerson DA (1999) Sequence variation in the human angiotensin converting enzyme. Nat Genet, 22, 59-62.
33. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F (1990) An insertion/ deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest, 86, 1343-1346.
34. Moran CN, Vassilopoulos C, Tsiokanos A et al. (2006) The associations of ACE polymorphisms with physical, physiological and skill parameters in adolescents. Eur J Hum Genet, 14, 332-339.
35. Myerson S, Hemingway H, Budget R, Martin J, Humphries S, Montgomery H (1999) Human angiotensin I-converting enzyme gene and endurance performance. J Appl Physiol, 87, 1313-1316.
36. Nazarov IB, Woods DR, Montgomery HE et al. (2001) The angiotensin converting enzyme I/D polymorphism in Russian athletes. Eur J Hum Genet, 9, 797-801.
37. Rico-Sanz J, Rankinen T, Joanisse DR et al. (2003) Associations between cardiorespiratory responses to exercise and the C34T AMPD1 gene polymorphism in the HERITAGE Family Study. Physiol Genomics, 14, 161-166.
38. Kostek MC, Delmonico MJ, Reichel JB et al. (2005) Muscle strength response to strength training is influenced by insulin-like growth factor 1 genotype in older adults. J Appl Physiol, 98, 2147-2154.
39. Maffulli N, Longo UG (2008) How do eccentric exercises work in tendinopathy? Rheumatology (Oxford), 47, 1444-1445.
40. Maffulli N, Longo UG, Testa V, Oliva F, Capasso G, Denaro V (2008) VISA-P score for patellar tendinopathy in males: adaptation to Italian. Disabil Rehabil, 30, 1621-1624.
41. Longo UG, Franceschi F, Ruzzini L et al. (2007) Characteristics at Haematoxylin and Eosin staining of ruptures of the long head of the biceps tendon. Br J Sports Med. December 10. [Epub ahead of print] doi: 10.1136/bjsm.2007.039016.
42. Longo UG, Franceschi F, Ruzzini L et al. (2008) Histopathology of the supraspinatus tendon in rotator cuff tears. Am J Sports Med, 36, 533-538.
43. Longo UG, Franceschi F, Ruzzini L et al. (2007) Light microscopic histology of supraspinatus tendon ruptures. Knee Surg Sports Traumatol Arthrosc, 15, 1390-1394.
44. Longo UG, Garau G, Denaro V, Maffulli N (2008) Surgical management of tendinopathy of biceps femoris tendon in athletes. Disabil Rehabil, 30, 1602-1607.
45. Longo UG, Ramamurthy C, Denaro V, Maffulli N (2008) Minimally invasive stripping for chronic Achilles tendinopathy. Disabil Rehabil, 30, 1709-1713.
46. Maffulli N, Longo UG (2008) Conservative management for tendinopathy: is there enough scientific evidence? Rheumatology (Oxford), 47, 390-391.
47. Maffulli N, Longo UG, Franceschi F, Rabitti C, Denaro V (2008) Movin and Bonar scores assess the same characteristics of tendon histology. Clin Orthop Relat Res, 466, 1605-1611.
48. Maffulli N, Longo UG, Gougoulias N, Denaro V (2008) Ipsilateral free semitendinosus tendon graft transfer for reconstruction of chronic tears of the Achilles tendon. BMC Musculoskelet Disord, 9, 100.
49. Franceschi F, Longo UG, Ruzzini L, Denaro V (2007) Isolated tuberculosis of the patellar tendon. J Bone Joint Surg Br, 89, 1525-1526.
50. Maganaris CN, Narici MV, Almekinders LC, Maffulli N (2004) Biomechanics and pathophysiology of overuse tendon injuries: ideas on insertional tendinopathy. Sports Med, 34, 1005-1017.
51. Jozsa L, Balint JB, Kannus P, Reffy A, Barzo M (1989) Distribution of blood groups in patients with tendon rupture. An analysis of 832 cases. J Bone Joint Surg Br, 71, 272-274.
52. Maffulli N, Reaper JA, Waterston SW, Ahya T (2000) ABO blood groups and Achilles tendon rupture in the Grampian Region of Scotland. Clin J Sport Med, 10, 269-271.
53. Mokone GG, Gajjar M, September AV et al. (2005) The guanine-thymine dinucleotide repeat polymorphism within the tenascin-C gene is associated with Achilles tendon injuries. Am J Sports Med, 33, 1016-1021.
54. Mokone GG, Schwellnus MP, Noakes TD, Collins M (2006) The COL5A1 gene and Achilles tendon pathology. Scand J Med Sci Sports, 16, 19-26.
55. Harvie P, Ostlere SJ, Teh J et al. (2004) Genetic influences in the aetiology of tears of the rotator cuff. Sibling risk of a full-thickness tear. J Bone Joint Surg Br, 86, 696-700.
56. Riley GP (2005) Gene expression and matrix turnover in overused and damaged tendons. Scand J Med Sci Sports, 15, 241-251.
57. Chiquet M, Renedo AS, Huber F, Fluck M (2003) How do fibroblasts translate mechanical signals into changes in extracellular matrix production? Matrix Biol, 22, 73-80.
58. Jones FS, Jones PL (2000) The tenascin family of ECM glycoproteins: structure, function, and regulation during embryonic development and tissue remodeling. Dev Dyn, 218, 235-259.
59. Murrell GA (2002) Understanding tendinopathies. Br J Sports Med, 36, 392-393.
60. Franceschi F, Longo UG, Ruzzini L, Rizzello G, Maffulli N, Denaro V (2008) No advantages in repairing a type II superior labrum anterior and posterior (SLAP) lesion when associated with rotator cuff repair in patients over age 50: a randomized controlled trial. Am J Sports Med, 36, 247-253.
61. Dowdy PA, O'Driscoll SW (1993) Shoulder instability. An analysis of family history. J Bone Joint Surg Br, 75, 782-784.
62. Flynn RK, Pedersen CL, Birmingham TB, Kirkley A, Jackowski D, Fowler PJ (2005) The familial predisposition toward tearing the anterior cruciate ligament: a case-control study. Am J Sports Med, 33, 23-28.
63. Khoschnau S, Melhus H, Jacobson A et al. (2008) Type I collagen {alpha}1 Sp1 polymorphism and the risk of cruciate ligament ruptures or shoulder dislocations. Am J Sports Med.
64. September AV, Schwellnus MP, Collins M (2007) Tendon and ligament injuries: the genetic component. Br J Sports Med, 41, 241-246; discussion 246.
65. Evans CH, Ghivizzani SC, Robbins PD (2008) Orthopedic gene therapy in 2008. Mol Ther, 17, 231-244.
66. Gerich TG, Kang R, Fu FH, Robbins PD, Evans CH (1997) Gene transfer to the patellar tendon. Knee Surg Sports Traumatol Arthrosc, 5, 118-123.
67. Gerich TG, Kang R, Fu FH, Robbins PD, Evans CH (1996) Gene transfer to the rabbit patellar tendon: potential for genetic enhancement of tendon and ligament healing. Gene Ther 3, 1089-1093.
68. Niyibizi C, Kavalkovich K, Yamaji T, Woo SL (2000) Type V collagen is increased during rabbit medial collateral ligament healing. Knee Surg Sports Traumatol Arthrosc, 8, 281-285.
69. Shimomura T, Jia F, Niyibizi C, Woo SL (2003) Antisense oligonucleotides reduce synthesis of procollagen alpha1 (V) chain in human patellar tendon fibroblasts: potential application in healing ligaments and tendons. Connect Tissue Res, 44, 167-172.
70. Bolt P, Clerk AN, Luu HH et al. (2007) BMP-14 gene therapy increases tendon tensile strength in a rat model of Achilles tendon injury. J Bone Joint Surg Am, 89, 1315-1320.
71. Lou J, Tu Y, Burns M, Silva MJ, Manske P (2001) BMP-12 gene transfer augmentation of lacerated tendon repair. J Orthop Res, 19, 1199-1202.
72. Majewski M, Betz O, Ochsner PE, Liu F, Porter RM, Evans CH (2008) Ex vivo adenoviral transfer of bone morphogenetic protein 12 (BMP-12) cDNA improves Achilles tendon healing in a rat model. Gene Ther, 15, 1139-1146.
73. Rickert M, Wang H, Wieloch P et al. (2005) Adenovirus-mediated gene transfer of growth and differentiation factor-5 into tenocytes and the healing rat Achilles tendon. Connect Tissue Res, 46, 175-183.
74. Nakamura N, Shino K, Natsuume T et al. (1998) Early biological effect of in vivo gene transfer of platelet-derived growth factor (PDGF)-B into healing patellar ligament. Gene Ther, 5, 1165-1170.
75. Dai Q, Manfield L, Wang Y, Murrell GA (2003) Adenovirus-mediated gene transfer to healing tendon-enhanced efficiency using a gelatin sponge. J Orthop Res, 21, 604-609.
76. Steinert AF, Weber M, Kunz M et al. (2008) In situ IGF-1 gene delivery to cells emerging from the injured anterior cruciate ligament. Biomaterials, 29, 904-916.
77. Brutsaert TD, Parra EJ (2006) What makes a champion? Explaining variation in human athletic performance. Respir Physiol Neurobiol, 151, 109-123.
78. Bryan A, Hutchison KE, Seals DR, Allen DL (2007) A transdisciplinary model integrating genetic, physiological, and psychological correlates of voluntary exercise. Health Psychol, 26, 30-39.
79. Maliuchenko NV, Sysoeva OV, Vediakov AM et al. (2007) Effect of 5HTT genetic polymorphism on aggression in athletes. Zh Vyssh Nerv Deiat Im I P Pavlova, 57, 276-281.
80. Ortega-Alonso A, Pedersen NL, Kujala UM et al. (2006) A twin study on the heritability of walking ability among older women. J Gerontol A Biol Sci Med Sci, 61, 1082-1085.
81. Stubbe JH, Boomsma DI, De Geus EJ (2005) Sports participation during adolescence: a shift from environmental to genetic factors. Med Sci Sports Exerc, 37, 563-570.
82. Hirschhorn JN, Daly MJ (2005) Genome-wide association studies for common diseases and complex traits. Nat Rev Genet, 6, 95-108.
83. Kraft P, Cox DG (2008) Study designs for genome-wide association studies. Adv Genet, 60, 465-504.
84. Seng KC, Seng CK (2008) The success of the genome-wide association approach: a brief story of a long struggle. Eur J Hum Genet, 16, 554-564.
85. Li M, Li C, Guan W (2008) Evaluation of coverage variation of SNP chips for genome-wide association studies. Eur J Hum Genet, 16, 635-643.
86. Maresso K, Broeckel U (2008) Genotyping platforms for mass-throughput genotyping with SNPs, including human genome-wide scans. Adv Genet, 60, 107-139.
87. Rankinen T, An P, Rice T et al. (2001) Genomic scan for exercise blood pressure in the Health, Risk Factors, Exercise Training and Genetics (HERITAGE) Family Study. Hypertension, 38, 30-37.
88. Wilkes T, Laux H, Foy CA (2007) Microarray data quality-review of current developments. Omics, 11, 1-13.
89. Lippi G, Franchini M, Guidi GC (2008) Doping in competition or doping in sport? Br Med Bull, 86, 95-107.
90. Unal M, Ozer Unal D (2004) Gene doping in sports. Sports Med, 34, 357-362.
91. Fedoruk MN, Rupert JL (2008) Myostatin inhibition: a potential performance enhancement strategy? Scand J Med Sci Sports, 18, 123-131.
92. Lippi G, Guidi G (2003) New scenarios in antidoping research. Clin Chem, 49, 2106-2107.
93. Bowers LD (2008) Testosterone doping: dealing with genetic differences in metabolism and excretion. J Clin Endocrinol Metab, 93, 2469-2471.
94. Schulze JJ, Lundmark J, Garle M, Skilving I, Ekstrom L, Rane A (2008) Doping test results dependent on genotype of UGT2B17, the major enzyme for testosterone glucuronidation. J Clin Endocrinol Metab, 93, 2500-2506.
95. Davids K, Baker J (2007) Genes, environment and sport performance: why the naturenurture dualism is no longer relevant. Sports Med, 37, 961-980.
96. Williams AG, Folland JP (2008) Similarity of polygenic profiles limits the potential for elite human physical performance. J Physiol, 586, 113-121.
97. Cuzin M (2001) DNA chips: a new tool for genetic analysis and diagnostics. Transfus Clin Biol, 8, 291-296.
98. Helge JW, Rehrer NJ, Pilegaard H et al. (2007) Increased fat oxidation and regulation of metabolic genes with ultraendurance exercise. Acta Physiol (Oxf), 191, 77-86.
99. Lippi G, Solero GP, Guidi G (2004) Athletes genotyping: ethical and legal issues. Int J Sports Med, 25, 159; author reply 160-151.
100. Keller P, Vollaard N, Babraj J, Ball D, Sewell DA, Timmons JA (2007) Using systems biology to define the essential biological networks responsible for adaptation to endurance exercise training. Biochem Soc Trans, 35, 1306-1309.